110 related articles for article (PubMed ID: 7525425)
1. Natural killer cell activity in stage I endometrial carcinoma: correlation with nuclear grading, myometrial invasion, and immunoreactivity of proliferating cell nuclear antigen.
Garzetti GG; Ciavattini A; Goteri G; Tranquilli AL; Muzzioli M; Fabris N; De Nictolis M; Romanini C
Gynecol Oncol; 1994 Oct; 55(1):111-4. PubMed ID: 7525425
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
[TBL] [Abstract][Full Text] [Related]
3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
4. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
[TBL] [Abstract][Full Text] [Related]
5. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
6. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
[TBL] [Abstract][Full Text] [Related]
7. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
8. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
9. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
10. CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma.
Shang S; Takai N; Nishida M; Miyazaki T; Nasu K; Miyakawa I
Int J Mol Med; 2003 Feb; 11(2):181-6. PubMed ID: 12525874
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters.
Lindahl B; Einarsdottir M; Iosif C; Ranstam J; Willén R
Anticancer Res; 1997; 17(3C):2297-302. PubMed ID: 9216705
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
Köhler U
Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
16. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
Hareyama H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
[TBL] [Abstract][Full Text] [Related]
17. MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion.
Nakao Y; Yokoyama M; Hara K; Koyamatsu Y; Yasunaga M; Araki Y; Watanabe Y; Iwasaka T
Gynecol Oncol; 2006 Aug; 102(2):343-7. PubMed ID: 16469365
[TBL] [Abstract][Full Text] [Related]
18. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
[TBL] [Abstract][Full Text] [Related]
19. A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging.
Atsukawa H; Sasaki H; Tada S
Gynecol Oncol; 1994 Sep; 54(3):298-306. PubMed ID: 8088606
[TBL] [Abstract][Full Text] [Related]
20. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.
Sakuragi N; Nishiya M; Ikeda K; Ohkouch T; Furth EE; Hareyama H; Satoh C; Fujimoto S
Gynecol Oncol; 1994 May; 53(2):183-9. PubMed ID: 8188077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
